Skip to content

The Effectiveness of a Chatbot Promoting Self-Care, Self-Monitoring and Motivation, and Social Support on Knowledge, Health Behaviors, and Biomarkers among People Risk to Hypertension: A Single-Blinded Randomized Controlled Trial

The Effectiveness of a Chatbot Promoting Self-Care, Self-Monitoring and Motivation, and Social Support on Knowledge, Health Behaviors, and Biomarkers among People Risk to Hypertension: A Single-Blinded Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260104001
Enrollment
92
Registered
2026-01-04
Start date
2026-01-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension hypertension, chatbot, self-care, self-monitoring, motivation, social support, biomarkers, risk people

Interventions

1. Nursing Intervention The nursing intervention consists of health education sessions conducted once a week for four weeks. Each session lasts two hours. The goal is to improve knowledge and promote
Experimental Behavioral,No Intervention No treatment
A Chatbot Promoting Self-Care, Self-Monitoring and Motivation, and Social Support,Routine Care

Sponsors

School of Nursing, University of Michigan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Participants will be males and females aged 18 to 65 years who are at risk of high blood pressure. A person will be considered at risk if they have at least one of the following conditions: Age 60 years or older Body mass index of 23 kg per square meter or higher Prehypertension, defined as systolic blood pressure between 120 and 139 mmHg or diastolic blood pressure between 80 and 89 mmHg A family history of high blood pressure in first degree relatives, including father, mother, grandfather, or grandmother Participants must also meet all of the following requirements: Have at least a secondary school education or basic skills to use a chatbot application Own a smartphone with the Line application and chatbot access Be able to read and write Thai Be oriented to time and place Have no hearing or visual impairment Have no signs of depression based on the two question screening tool and no cognitive impairment based on the Thai Mental State Examination score of at least 23 points Be willing to participate in the study and provide informed consent

Exclusion criteria

Exclusion criteria: Participants will be excluded from the study if they meet any of the following conditions: Individuals who are at high risk for moderate to severe obstructive sleep apnea based on the STOP BANG screening questionnaire. Those with a score of five points or higher will be excluded. Individuals with a history of acute high blood pressure within the past three months. Individuals who have used nonsteroidal anti inflammatory drugs within the past three months. Individuals with health conditions that limit participation in the intervention or exercise activities, such as heart disease, asthma, or chronic obstructive pulmonary disease. Individuals with serious symptoms that interfere with participation, such as joint arthritis, severe pain with a pain score of five or more out of ten, or high fever above thirty eight point five degrees Celsius. Individuals who are unable to participate in all study activities for the full twelve week study period.

Design outcomes

Primary

MeasureTime frame
Knowledge before and after 12 weeks attending intervention 3)Hypertensive knowledge questionnaires

Secondary

MeasureTime frame
Behaviors before and after 12 weeks attending intervention 4) Health-behaviors checklist,Biomarkers before and after 12 weeks attending intervention Biomarkers

Countries

Thailand

Contacts

Public ContactSamoraphop Banharak

Faculty of Nursing, Khon Kaen University, 40002

sbanharak@kku.ac.th0619308118

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026